StructureDefinition-2.16.840.1.113883.10.20.22.4.23

Sourcehl7.cda.us.ccdar2dot2#current:Consolidated CDA Release 2.1 StructureDefinition Publication (v5.0.0)
resourceTypeStructureDefinition
id2.16.840.1.113883.10.20.22.4.23
canonicalhttp://hl7.org/fhir/cda/ccda/StructureDefinition/2.16.840.1.113883.10.20.22.4.23
version2.2
statusactive
publisherHealth Level Seven
nameMedicationInformation
titleMedication Information
date2021-11-24T17:43:01+00:00
descriptionA medication should be recorded as a pre-coordinated ingredient + strength + dose form (e.g., metoprolol 25mg tablet, amoxicillin 400mg/5mL suspension) where possible. This includes RxNorm codes whose Term Type is SCD (semantic clinical drug), SBD (semantic brand drug), GPCK (generic pack), BPCK (brand pack). The dose (doseQuantity) represents how many of the consumables are to be administered at each administration event. As a result, the dose is always relative to the consumable. Thus, a patient consuming a single "metoprolol 25mg tablet" per administration will have a doseQuantity of "1", whereas a patient consuming "metoprolol" will have a dose of "25 mg".
jurisdictionsus
fhirVersion4.0.1
kindresource
abstractfalse
sdTtypeManufacturedProduct
derivationconstraint
basehttp://hl7.org/fhir/cda/StructureDefinition/ManufacturedProduct
Usages
Name Flags Card. Type Description & Constraints doco
. . ManufacturedProduct
. . . classCode 1..1
. . . Slices for templateId Slice: Unordered, Open by value:root, value:extension
. . . . templateId:primary 1..1
. . . . . root 1..1 Required Pattern: 2.16.840.1.113883.10.20.22.4.23
. . . . . extension 1..1 Required Pattern: 2014-06-09
. . . id 0..*
. . . manufacturedMaterial 1..1 A medication should be recorded as a pre-coordinated ingredient + strength + dose form (e.g., “metoprolol 25mg tablet”, “amoxicillin 400mg/5mL suspension”) where possible. This includes RxNorm codes whose Term Type is SCD (semantic clinical drug), SBD (semantic brand drug), GPCK (generic pack), BPCK (brand pack).
. . . . code 1..1 Binding: Medication Clinical Drug ( required )
. . . . . translation 0..* Binding: Clinical Substance ( example )
. . . manufacturerOrganization 0..1

doco Documentation for this format

Produced 08 Sep 2023